In this episode, Michael Evans, RPh, MBA, FASHP, Chief Pharmacy Officer for Enterprise Pharmacy at Geisinger, discusses key pharmacy priorities including biosimilar adoption, the impact of the Inflation Reduction Act, cell and gene therapy readiness, and strategies to expand access and strengthen pharmacy operations.